• Citer

HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide.

par Di Leo, Angelo ;Larsimont, Denis ;Gancberg, David ;Järvinen, Tero;Beauduin, Marc;Vindevoghel, Anita;Michel, Jeffrey;Focan, Christian;Ries, Fernand;Gobert, P H;Closon-Dejardin, Marie Thérèse;Dolci, Stella;Rouas, Ghizlane;Paesmans, Marianne ;Lobelle, Jean Pierre;Isola, Jorma;Piccart-Gebhart, Martine
Référence Annals of oncology, 12, 8, page (1081-1089)
Publication Publié, 2001-08

Article révisé par les pairs

• Détails
• Contenu

Titre:	HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide.
Auteur:	Di Leo, Angelo; Larsimont, Denis; Gancberg, David; Järvinen, Tero; Beauduin, Marc; Vindevoghel, Anita; Michel, Jeffrey; Focan, Christian; Ries, Fernand; Gobert, P H; Closon-Dejardin, Marie Thérèse; Dolci, Stella; Rouas, Ghizlane; Paesmans, Marianne; Lobelle, Jean Pierre; Isola, Jorma; Piccart-Gebhart, Martine
Informations sur la publication:	Annals of oncology, 12, 8, page (1081-1089)
Statut de publication:	Publié, 2001-08
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Antigens, Neoplasm
	Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Breast Neoplasms -- chemistry
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- surgery
	Chemotherapy, Adjuvant
	Confidence Intervals
	Cyclophosphamide -- administration & dosage
	DNA Topoisomerases, Type II, Eukaryotic -- analysis
	DNA-Binding Proteins
	Epirubicin -- administration & dosage
	Female
	Fluorouracil -- administration & dosage
	Genes, erbB-2 -- genetics
	Humans
	Methotrexate -- administration & dosage
	Middle Aged
	Predictive Value of Tests
	Prognosis
	Receptor, erbB-2 -- analysis
	Retrospective Studies
	Treatment Outcome
	Tumor Markers, Biological -- analysis
Note générale:	Clinical Trial
	Clinical Trial, Phase III
	Comparative Study
	Journal Article
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:pmid/11583189